ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global MuA Recombinase Market Research Report 2025
Published Date: November 2025
|
Report Code: QYRE-Auto-36Y19978
Home | Market Reports | Science| Biological Sciences
Global MuA Recombinase Market Research Report 2025
BUY CHAPTERS

Global MuA Recombinase Market Research Report 2025

Code: QYRE-Auto-36Y19978
Report
November 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
MU
Domus Biotechnologies
Thermo Fisher Scientific
MyBioSource
Addgene
Sigma-aldrich
New England Biolabs
Promega
Bio Rad Laboratories
Qiagen NV
Lucigen
Takara Bio
Invitrogen
Clontech
Cell Biolabs
Bio-Techne

MuA Recombinase Market Size

The global market for MuA Recombinase was valued at US$ 78.00 million in the year 2024 and is projected to reach a revised size of US$ 241 million by 2031, growing at a CAGR of 17.0% during the forecast period.

MuA Recombinase Market

MuA Recombinase Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on MuA Recombinase competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
MuA transposase is derived from the MuA gene of bacteriophage Mu, which can catalyze the insertion of DNA from bacteriophage Mu into the host genome, or cut out from the host genome and transfer to other locations. The recombinantly expressed product can catalyze the insertion of donor genes into receptor DNA, and complete the transposition by recognizing the IR sequence, forming a transposition complex (4-mer), cutting the target DNA and reconnecting it.
The price of MuA transposase varies by supplier, product specifications and region, and is generally between $100 and $1,300 per unit. With the rapid development of genome editing and functional genomics research, the market demand for MuA transposase continues to grow. According to a report by Verified Market Research, the molecular biology enzyme and reagent market is expected to grow from $19.3 billion in 2023 to $69.4 billion in 2031, with an average annual growth rate of 17.35%. This trend has promoted the widespread use of MuA transposase in scientific research and industrial applications, especially in high-throughput mutation library construction and genome integration research. At the same time, suppliers continue to launch efficient and low-cost MuA transposase products to meet the market demand for high-quality scientific research reagents.

Report Scope

This report aims to provide a comprehensive presentation of the global market for MuA Recombinase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MuA Recombinase.
The MuA Recombinase market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global MuA Recombinase market comprehensively. Regional market sizes, concerning products by Type, by Application, by Origin and Structure and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the MuA Recombinase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Origin and Structure and by regions.

Scope of MuA Recombinase Market Report

Report Metric Details
Report Name MuA Recombinase Market
Accounted market size in year US$ 78.00 million
Forecasted market size in 2031 US$ 241 million
CAGR 17.0%
Base Year year
Forecasted years 2025 - 2031
1. Market Segmentation by Product Type
  • Wild-type MuA recombinase: Derived from the natural bacteriophage Mu, catalyzes transposition and integration reactions, used in basic research and teaching. Market share: 34%
  • Engineering MuA recombinase: Optimized through site-directed mutagenesis or protein engineering to enhance activity and site specificity, widely used in synthetic biology and genetic engineering. Market share: 36%
  • Chimeric/Fusion MuA Recombinase: Combines the MuA domain with other DNA-binding proteins (such as TALE, dCas9) to achieve programmable site-directed insertion. Market share: 20%
Classification by Application System
  • Gene Editing Systems: Used as DNA insertion or tag construction enzymes, suitable for prokaryotic and eukaryotic cell gene modification.
  • Transposition Mutant Library Systems: Used for random insertion mutation studies, combined with high-throughput sequencing for functional gene screening.
  • Vector Integration Systems: Integrates exogenous fragments into the host genome to achieve stable expression or pathway reconstruction.
  • Synthetic Biology Modular Assembly Systems: Enables automated connection in modular design and multi-gene synthetic pathway construction.
  • Classification by Performance Parameters：High Activity Type: Enzyme catalytic rate increased by 2–3 times, suitable for large-scale transposition reactions. High Specificity: Insertion error rate <0.5%, suitable for precise gene editing scenarios. Heat-Stable: Maintains activity at 45–60℃, suitable for industrial reaction systems. Inducible and Controlled: Transposation reactions can be initiated via chemical or photocontrolled signals, achieving process control.
  • 2. Upstream and Downstream Analysis
  • Upstream: Raw Materials: Recombinant protein expression vectors, E. coli host strains, buffer components, purification resins (Ni-NTA, Sepharose), freeze-drying excipients. Core Equipment: Fermenters, chromatography systems, high-speed centrifuges, quality control instruments (HPLC, SDS-PAGE).
  • Midstream: Process Flow: Gene cloning → Expression induction → Purification and concentration → Stabilization formulation development → Activity validation. Product Forms: Liquid reagents, lyophilized powders, reaction premixes, and high-throughput kits.
  • Downstream: Application Industries: Gene editing (CRISPR-based systems), synthetic biology, drug screening, microbial factories, functional genomics research. Typical Clients: Research institutions, biopharmaceutical companies, synthetic biology laboratories, and diagnostic companies.
  • 3. Technological Trends and Innovation Directions
  • Programmable Fusion Enzyme Systems: Integrating MuA with CRISPR or TALE systems to achieve specific site transposition and precise DNA insertion, expanding its application in site-directed editing.
  • High-Throughput Reaction Platformization: Combining microfluidic chips with automated liquid handling to achieve parallel processing of thousands of transposition reactions, significantly improving library construction efficiency.
  • AI-Driven Protein Structure Optimization: Utilizing deep learning to predict MuA structural mutations and DNA binding domain optimization directions to develop high-performance engineered enzymes.
  • Biocompatibility and Industrial Scale-Up: Developing more stable, shear-resistant industrial-grade MuA enzyme systems for large-scale DNA assembly and synthetic pathway construction.
  • 4. Market Prospects and Development Trends
  • With the rapid rise of gene editing and synthetic biology, the MuA recombinase market is entering a period of rapid development. The global market is projected to grow at a CAGR of approximately 17% between 2024 and 2029; the Asia-Pacific region (especially China, Japan, and Singapore) will see the fastest growth, exceeding 19% annually; the North American and European markets are maturing, focusing on technological upgrades and the expansion of new applications. Key factors driving growth include: rapidly growing demand for high-throughput genome editing; the integrated application of transposable vectors and intelligent editing systems; breakthroughs in AI and protein engineering technologies that enhance enzyme performance; and the extension of the synthetic biology industry chain driving the market for novel enzymes.
Segment by Type
  • Standard Active Enzyme
  • High Concentration Enzyme
Segment by Origin and Structure
  • Wild-type MuA Recombinase
  • Mutant MuA Recombinase
  • Engineered MuA Recombinase
  • Chimeric MuA Recombinase
Segment by Function and Catalytic Mechanism
  • DNA Transposase-type MuA
  • DNA Integrase-type MuA
  • Others
Segment by Application
  • Biopharmaceuticals
  • Vaccine Development
  • Functional Genomics Research
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Domus Biotechnologies, Thermo Fisher Scientific, MyBioSource, Addgene, Sigma-Aldrich, New England Biolabs, Promega, Bio-Rad Laboratories, Qiagen, Lucigen, Takara Bio, Invitrogen, Clontech, Cell Biolabs, Bio-Techne
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of MuA Recombinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of MuA Recombinase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is MuA Recombinase Market growing?

Ans: The MuA Recombinase Market witnessing a CAGR of 17.0% during the forecast period 2025-2031.

What is the MuA Recombinase Market size in 2031?

Ans: The MuA Recombinase Market size in 2031 will be US$ 241 million.

Who are the main players in the MuA Recombinase Market report?

Ans: The main players in the MuA Recombinase Market are Domus Biotechnologies, Thermo Fisher Scientific, MyBioSource, Addgene, Sigma-Aldrich, New England Biolabs, Promega, Bio-Rad Laboratories, Qiagen, Lucigen, Takara Bio, Invitrogen, Clontech, Cell Biolabs, Bio-Techne

What are the Application segmentation covered in the MuA Recombinase Market report?

Ans: The Applications covered in the MuA Recombinase Market report are Biopharmaceuticals, Vaccine Development, Functional Genomics Research, Others

What are the Type segmentation covered in the MuA Recombinase Market report?

Ans: The Types covered in the MuA Recombinase Market report are Standard Active Enzyme, High Concentration Enzyme

1 MuA Recombinase Market Overview
1.1 Product Definition
1.2 MuA Recombinase by Type
1.2.1 Global MuA Recombinase Market Value Comparison by Type (2024 VS 2031)
1.2.2 Standard Active Enzyme
1.2.3 High Concentration Enzyme
1.3 MuA Recombinase by Origin and Structure
1.3.1 Global MuA Recombinase Market Value Comparison by Origin and Structure: 2024 VS 2031
1.3.2 Wild-type MuA Recombinase
1.3.3 Mutant MuA Recombinase
1.3.4 Engineered MuA Recombinase
1.3.5 Chimeric MuA Recombinase
1.4 MuA Recombinase by Function and Catalytic Mechanism
1.4.1 Global MuA Recombinase Market Value Comparison by Function and Catalytic Mechanism: 2024 VS 2031
1.4.2 DNA Transposase-type MuA
1.4.3 DNA Integrase-type MuA
1.4.4 Others
1.5 MuA Recombinase by Application
1.5.1 Global MuA Recombinase Market Value by Application (2024 VS 2031)
1.5.2 Biopharmaceuticals
1.5.3 Vaccine Development
1.5.4 Functional Genomics Research
1.5.5 Others
1.6 Global MuA Recombinase Market Size Estimates and Forecasts
1.6.1 Global MuA Recombinase Revenue 2020-2031
1.6.2 Global MuA Recombinase Sales 2020-2031
1.6.3 Global MuA Recombinase Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 MuA Recombinase Market Competition by Manufacturers
2.1 Global MuA Recombinase Sales Market Share by Manufacturers (2020-2025)
2.2 Global MuA Recombinase Revenue Market Share by Manufacturers (2020-2025)
2.3 Global MuA Recombinase Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of MuA Recombinase, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of MuA Recombinase, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of MuA Recombinase, Product Type & Application
2.7 Global Key Manufacturers of MuA Recombinase, Date of Enter into This Industry
2.8 Global MuA Recombinase Market Competitive Situation and Trends
2.8.1 Global MuA Recombinase Market Concentration Rate
2.8.2 The Global 5 and 10 Largest MuA Recombinase Players Market Share by Revenue
2.8.3 Global MuA Recombinase Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global MuA Recombinase Market Scenario by Region
3.1 Global MuA Recombinase Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global MuA Recombinase Sales by Region: 2020-2031
3.2.1 Global MuA Recombinase Sales by Region: 2020-2025
3.2.2 Global MuA Recombinase Sales by Region: 2026-2031
3.3 Global MuA Recombinase Revenue by Region: 2020-2031
3.3.1 Global MuA Recombinase Revenue by Region: 2020-2025
3.3.2 Global MuA Recombinase Revenue by Region: 2026-2031
3.4 North America MuA Recombinase Market Facts & Figures by Country
3.4.1 North America MuA Recombinase Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America MuA Recombinase Sales by Country (2020-2031)
3.4.3 North America MuA Recombinase Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe MuA Recombinase Market Facts & Figures by Country
3.5.1 Europe MuA Recombinase Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe MuA Recombinase Sales by Country (2020-2031)
3.5.3 Europe MuA Recombinase Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific MuA Recombinase Market Facts & Figures by Region
3.6.1 Asia Pacific MuA Recombinase Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific MuA Recombinase Sales by Region (2020-2031)
3.6.3 Asia Pacific MuA Recombinase Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America MuA Recombinase Market Facts & Figures by Country
3.7.1 Latin America MuA Recombinase Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America MuA Recombinase Sales by Country (2020-2031)
3.7.3 Latin America MuA Recombinase Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa MuA Recombinase Market Facts & Figures by Country
3.8.1 Middle East and Africa MuA Recombinase Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa MuA Recombinase Sales by Country (2020-2031)
3.8.3 Middle East and Africa MuA Recombinase Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global MuA Recombinase Sales by Type (2020-2031)
4.1.1 Global MuA Recombinase Sales by Type (2020-2025)
4.1.2 Global MuA Recombinase Sales by Type (2026-2031)
4.1.3 Global MuA Recombinase Sales Market Share by Type (2020-2031)
4.2 Global MuA Recombinase Revenue by Type (2020-2031)
4.2.1 Global MuA Recombinase Revenue by Type (2020-2025)
4.2.2 Global MuA Recombinase Revenue by Type (2026-2031)
4.2.3 Global MuA Recombinase Revenue Market Share by Type (2020-2031)
4.3 Global MuA Recombinase Price by Type (2020-2031)
5 Segment by Application
5.1 Global MuA Recombinase Sales by Application (2020-2031)
5.1.1 Global MuA Recombinase Sales by Application (2020-2025)
5.1.2 Global MuA Recombinase Sales by Application (2026-2031)
5.1.3 Global MuA Recombinase Sales Market Share by Application (2020-2031)
5.2 Global MuA Recombinase Revenue by Application (2020-2031)
5.2.1 Global MuA Recombinase Revenue by Application (2020-2025)
5.2.2 Global MuA Recombinase Revenue by Application (2026-2031)
5.2.3 Global MuA Recombinase Revenue Market Share by Application (2020-2031)
5.3 Global MuA Recombinase Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Domus Biotechnologies
6.1.1 Domus Biotechnologies Company Information
6.1.2 Domus Biotechnologies Description and Business Overview
6.1.3 Domus Biotechnologies MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Domus Biotechnologies MuA Recombinase Product Portfolio
6.1.5 Domus Biotechnologies Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thermo Fisher Scientific MuA Recombinase Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 MyBioSource
6.3.1 MyBioSource Company Information
6.3.2 MyBioSource Description and Business Overview
6.3.3 MyBioSource MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.3.4 MyBioSource MuA Recombinase Product Portfolio
6.3.5 MyBioSource Recent Developments/Updates
6.4 Addgene
6.4.1 Addgene Company Information
6.4.2 Addgene Description and Business Overview
6.4.3 Addgene MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Addgene MuA Recombinase Product Portfolio
6.4.5 Addgene Recent Developments/Updates
6.5 Sigma-Aldrich
6.5.1 Sigma-Aldrich Company Information
6.5.2 Sigma-Aldrich Description and Business Overview
6.5.3 Sigma-Aldrich MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sigma-Aldrich MuA Recombinase Product Portfolio
6.5.5 Sigma-Aldrich Recent Developments/Updates
6.6 New England Biolabs
6.6.1 New England Biolabs Company Information
6.6.2 New England Biolabs Description and Business Overview
6.6.3 New England Biolabs MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.6.4 New England Biolabs MuA Recombinase Product Portfolio
6.6.5 New England Biolabs Recent Developments/Updates
6.7 Promega
6.7.1 Promega Company Information
6.7.2 Promega Description and Business Overview
6.7.3 Promega MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Promega MuA Recombinase Product Portfolio
6.7.5 Promega Recent Developments/Updates
6.8 Bio-Rad Laboratories
6.8.1 Bio-Rad Laboratories Company Information
6.8.2 Bio-Rad Laboratories Description and Business Overview
6.8.3 Bio-Rad Laboratories MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bio-Rad Laboratories MuA Recombinase Product Portfolio
6.8.5 Bio-Rad Laboratories Recent Developments/Updates
6.9 Qiagen
6.9.1 Qiagen Company Information
6.9.2 Qiagen Description and Business Overview
6.9.3 Qiagen MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Qiagen MuA Recombinase Product Portfolio
6.9.5 Qiagen Recent Developments/Updates
6.10 Lucigen
6.10.1 Lucigen Company Information
6.10.2 Lucigen Description and Business Overview
6.10.3 Lucigen MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Lucigen MuA Recombinase Product Portfolio
6.10.5 Lucigen Recent Developments/Updates
6.11 Takara Bio
6.11.1 Takara Bio Company Information
6.11.2 Takara Bio Description and Business Overview
6.11.3 Takara Bio MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Takara Bio MuA Recombinase Product Portfolio
6.11.5 Takara Bio Recent Developments/Updates
6.12 Invitrogen
6.12.1 Invitrogen Company Information
6.12.2 Invitrogen Description and Business Overview
6.12.3 Invitrogen MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Invitrogen MuA Recombinase Product Portfolio
6.12.5 Invitrogen Recent Developments/Updates
6.13 Clontech
6.13.1 Clontech Company Information
6.13.2 Clontech Description and Business Overview
6.13.3 Clontech MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Clontech MuA Recombinase Product Portfolio
6.13.5 Clontech Recent Developments/Updates
6.14 Cell Biolabs
6.14.1 Cell Biolabs Company Information
6.14.2 Cell Biolabs Description and Business Overview
6.14.3 Cell Biolabs MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Cell Biolabs MuA Recombinase Product Portfolio
6.14.5 Cell Biolabs Recent Developments/Updates
6.15 Bio-Techne
6.15.1 Bio-Techne Company Information
6.15.2 Bio-Techne Description and Business Overview
6.15.3 Bio-Techne MuA Recombinase Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bio-Techne MuA Recombinase Product Portfolio
6.15.5 Bio-Techne Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 MuA Recombinase Industry Chain Analysis
7.2 MuA Recombinase Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 MuA Recombinase Production Mode & Process Analysis
7.4 MuA Recombinase Sales and Marketing
7.4.1 MuA Recombinase Sales Channels
7.4.2 MuA Recombinase Distributors
7.5 MuA Recombinase Customer Analysis
8 MuA Recombinase Market Dynamics
8.1 MuA Recombinase Industry Trends
8.2 MuA Recombinase Market Drivers
8.3 MuA Recombinase Market Challenges
8.4 MuA Recombinase Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
MU
Domus Biotechnologies
Thermo Fisher Scientific
MyBioSource
Addgene
Sigma-aldrich
New England Biolabs
Promega
Bio Rad Laboratories
Qiagen NV
Lucigen
Takara Bio
Invitrogen
Clontech
Cell Biolabs
Bio-Techne
List of Tables
 Table 1. Global MuA Recombinase Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global MuA Recombinase Market Value by Origin and Structure, (US$ Million) & (2024 VS 2031)
 Table 3. Global MuA Recombinase Market Value by Function and Catalytic Mechanism, (US$ Million) & (2024 VS 2031)
 Table 4. Global MuA Recombinase Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 5. Global MuA Recombinase Market Competitive Situation by Manufacturers in 2024
 Table 6. Global MuA Recombinase Sales (K Units) of Key Manufacturers (2020-2025)
 Table 7. Global MuA Recombinase Sales Market Share by Manufacturers (2020-2025)
 Table 8. Global MuA Recombinase Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 9. Global MuA Recombinase Revenue Share by Manufacturers (2020-2025)
 Table 10. Global Market MuA Recombinase Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 11. Global Key Players of MuA Recombinase, Industry Ranking, 2022 VS 2023 VS 2024
 Table 12. Global Key Manufacturers of MuA Recombinase, Manufacturing Sites & Headquarters
 Table 13. Global Key Manufacturers of MuA Recombinase, Product Type & Application
 Table 14. Global Key Manufacturers of MuA Recombinase, Date of Enter into This Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global MuA Recombinase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MuA Recombinase as of 2024)
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global MuA Recombinase Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 19. Global MuA Recombinase Sales by Region (2020-2025) & (K Units)
 Table 20. Global MuA Recombinase Sales Market Share by Region (2020-2025)
 Table 21. Global MuA Recombinase Sales by Region (2026-2031) & (K Units)
 Table 22. Global MuA Recombinase Sales Market Share by Region (2026-2031)
 Table 23. Global MuA Recombinase Revenue by Region (2020-2025) & (US$ Million)
 Table 24. Global MuA Recombinase Revenue Market Share by Region (2020-2025)
 Table 25. Global MuA Recombinase Revenue by Region (2026-2031) & (US$ Million)
 Table 26. Global MuA Recombinase Revenue Market Share by Region (2026-2031)
 Table 27. North America MuA Recombinase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. North America MuA Recombinase Sales by Country (2020-2025) & (K Units)
 Table 29. North America MuA Recombinase Sales by Country (2026-2031) & (K Units)
 Table 30. North America MuA Recombinase Revenue by Country (2020-2025) & (US$ Million)
 Table 31. North America MuA Recombinase Revenue by Country (2026-2031) & (US$ Million)
 Table 32. Europe MuA Recombinase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 33. Europe MuA Recombinase Sales by Country (2020-2025) & (K Units)
 Table 34. Europe MuA Recombinase Sales by Country (2026-2031) & (K Units)
 Table 35. Europe MuA Recombinase Revenue by Country (2020-2025) & (US$ Million)
 Table 36. Europe MuA Recombinase Revenue by Country (2026-2031) & (US$ Million)
 Table 37. Asia Pacific MuA Recombinase Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 38. Asia Pacific MuA Recombinase Sales by Region (2020-2025) & (K Units)
 Table 39. Asia Pacific MuA Recombinase Sales by Region (2026-2031) & (K Units)
 Table 40. Asia Pacific MuA Recombinase Revenue by Region (2020-2025) & (US$ Million)
 Table 41. Asia Pacific MuA Recombinase Revenue by Region (2026-2031) & (US$ Million)
 Table 42. Latin America MuA Recombinase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Latin America MuA Recombinase Sales by Country (2020-2025) & (K Units)
 Table 44. Latin America MuA Recombinase Sales by Country (2026-2031) & (K Units)
 Table 45. Latin America MuA Recombinase Revenue by Country (2020-2025) & (US$ Million)
 Table 46. Latin America MuA Recombinase Revenue by Country (2026-2031) & (US$ Million)
 Table 47. Middle East and Africa MuA Recombinase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 48. Middle East and Africa MuA Recombinase Sales by Country (2020-2025) & (K Units)
 Table 49. Middle East and Africa MuA Recombinase Sales by Country (2026-2031) & (K Units)
 Table 50. Middle East and Africa MuA Recombinase Revenue by Country (2020-2025) & (US$ Million)
 Table 51. Middle East and Africa MuA Recombinase Revenue by Country (2026-2031) & (US$ Million)
 Table 52. Global MuA Recombinase Sales (K Units) by Type (2020-2025)
 Table 53. Global MuA Recombinase Sales (K Units) by Type (2026-2031)
 Table 54. Global MuA Recombinase Sales Market Share by Type (2020-2025)
 Table 55. Global MuA Recombinase Sales Market Share by Type (2026-2031)
 Table 56. Global MuA Recombinase Revenue (US$ Million) by Type (2020-2025)
 Table 57. Global MuA Recombinase Revenue (US$ Million) by Type (2026-2031)
 Table 58. Global MuA Recombinase Revenue Market Share by Type (2020-2025)
 Table 59. Global MuA Recombinase Revenue Market Share by Type (2026-2031)
 Table 60. Global MuA Recombinase Price (US$/Unit) by Type (2020-2025)
 Table 61. Global MuA Recombinase Price (US$/Unit) by Type (2026-2031)
 Table 62. Global MuA Recombinase Sales (K Units) by Application (2020-2025)
 Table 63. Global MuA Recombinase Sales (K Units) by Application (2026-2031)
 Table 64. Global MuA Recombinase Sales Market Share by Application (2020-2025)
 Table 65. Global MuA Recombinase Sales Market Share by Application (2026-2031)
 Table 66. Global MuA Recombinase Revenue (US$ Million) by Application (2020-2025)
 Table 67. Global MuA Recombinase Revenue (US$ Million) by Application (2026-2031)
 Table 68. Global MuA Recombinase Revenue Market Share by Application (2020-2025)
 Table 69. Global MuA Recombinase Revenue Market Share by Application (2026-2031)
 Table 70. Global MuA Recombinase Price (US$/Unit) by Application (2020-2025)
 Table 71. Global MuA Recombinase Price (US$/Unit) by Application (2026-2031)
 Table 72. Domus Biotechnologies Company Information
 Table 73. Domus Biotechnologies Description and Business Overview
 Table 74. Domus Biotechnologies MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Domus Biotechnologies MuA Recombinase Product
 Table 76. Domus Biotechnologies Recent Developments/Updates
 Table 77. Thermo Fisher Scientific Company Information
 Table 78. Thermo Fisher Scientific Description and Business Overview
 Table 79. Thermo Fisher Scientific MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Thermo Fisher Scientific MuA Recombinase Product
 Table 81. Thermo Fisher Scientific Recent Developments/Updates
 Table 82. MyBioSource Company Information
 Table 83. MyBioSource Description and Business Overview
 Table 84. MyBioSource MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. MyBioSource MuA Recombinase Product
 Table 86. MyBioSource Recent Developments/Updates
 Table 87. Addgene Company Information
 Table 88. Addgene Description and Business Overview
 Table 89. Addgene MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Addgene MuA Recombinase Product
 Table 91. Addgene Recent Developments/Updates
 Table 92. Sigma-Aldrich Company Information
 Table 93. Sigma-Aldrich Description and Business Overview
 Table 94. Sigma-Aldrich MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Sigma-Aldrich MuA Recombinase Product
 Table 96. Sigma-Aldrich Recent Developments/Updates
 Table 97. New England Biolabs Company Information
 Table 98. New England Biolabs Description and Business Overview
 Table 99. New England Biolabs MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. New England Biolabs MuA Recombinase Product
 Table 101. New England Biolabs Recent Developments/Updates
 Table 102. Promega Company Information
 Table 103. Promega Description and Business Overview
 Table 104. Promega MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 105. Promega MuA Recombinase Product
 Table 106. Promega Recent Developments/Updates
 Table 107. Bio-Rad Laboratories Company Information
 Table 108. Bio-Rad Laboratories Description and Business Overview
 Table 109. Bio-Rad Laboratories MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 110. Bio-Rad Laboratories MuA Recombinase Product
 Table 111. Bio-Rad Laboratories Recent Developments/Updates
 Table 112. Qiagen Company Information
 Table 113. Qiagen Description and Business Overview
 Table 114. Qiagen MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 115. Qiagen MuA Recombinase Product
 Table 116. Qiagen Recent Developments/Updates
 Table 117. Lucigen Company Information
 Table 118. Lucigen Description and Business Overview
 Table 119. Lucigen MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 120. Lucigen MuA Recombinase Product
 Table 121. Lucigen Recent Developments/Updates
 Table 122. Takara Bio Company Information
 Table 123. Takara Bio Description and Business Overview
 Table 124. Takara Bio MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 125. Takara Bio MuA Recombinase Product
 Table 126. Takara Bio Recent Developments/Updates
 Table 127. Invitrogen Company Information
 Table 128. Invitrogen Description and Business Overview
 Table 129. Invitrogen MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 130. Invitrogen MuA Recombinase Product
 Table 131. Invitrogen Recent Developments/Updates
 Table 132. Clontech Company Information
 Table 133. Clontech Description and Business Overview
 Table 134. Clontech MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 135. Clontech MuA Recombinase Product
 Table 136. Clontech Recent Developments/Updates
 Table 137. Cell Biolabs Company Information
 Table 138. Cell Biolabs Description and Business Overview
 Table 139. Cell Biolabs MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 140. Cell Biolabs MuA Recombinase Product
 Table 141. Cell Biolabs Recent Developments/Updates
 Table 142. Bio-Techne Company Information
 Table 143. Bio-Techne Description and Business Overview
 Table 144. Bio-Techne MuA Recombinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 145. Bio-Techne MuA Recombinase Product
 Table 146. Bio-Techne Recent Developments/Updates
 Table 147. Key Raw Materials Lists
 Table 148. Raw Materials Key Suppliers Lists
 Table 149. MuA Recombinase Distributors List
 Table 150. MuA Recombinase Customers List
 Table 151. MuA Recombinase Market Trends
 Table 152. MuA Recombinase Market Drivers
 Table 153. MuA Recombinase Market Challenges
 Table 154. MuA Recombinase Market Restraints
 Table 155. Research Programs/Design for This Report
 Table 156. Key Data Information from Secondary Sources
 Table 157. Key Data Information from Primary Sources
 Table 158. Authors List of This Report


List of Figures
 Figure 1. Product Picture of MuA Recombinase
 Figure 2. Global MuA Recombinase Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global MuA Recombinase Market Share by Type: 2024 & 2031
 Figure 4. Standard Active Enzyme Product Picture
 Figure 5. High Concentration Enzyme Product Picture
 Figure 6. Global MuA Recombinase Market Value by Origin and Structure, (US$ Million) & (2020-2031)
 Figure 7. Global MuA Recombinase Market Share by Origin and Structure: 2024 VS 2031
 Figure 8. Wild-type MuA Recombinase Product Picture
 Figure 9. Mutant MuA Recombinase Product Picture
 Figure 10. Engineered MuA Recombinase Product Picture
 Figure 11. Chimeric MuA Recombinase Product Picture
 Figure 12. Global MuA Recombinase Market Value by Function and Catalytic Mechanism, (US$ Million) & (2020-2031)
 Figure 13. Global MuA Recombinase Market Share by Function and Catalytic Mechanism: 2024 VS 2031
 Figure 14. DNA Transposase-type MuA Product Picture
 Figure 15. DNA Integrase-type MuA Product Picture
 Figure 16. Others Product Picture
 Figure 17. Global MuA Recombinase Market Value by Application (2020-2031) & (US$ Million)
 Figure 18. Global MuA Recombinase Market Share by Application: 2024 & 2031
 Figure 19. Biopharmaceuticals
 Figure 20. Vaccine Development
 Figure 21. Functional Genomics Research
 Figure 22. Others
 Figure 23. Global MuA Recombinase Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 24. Global MuA Recombinase Market Size (2020-2031) & (US$ Million)
 Figure 25. Global MuA Recombinase Sales (2020-2031) & (K Units)
 Figure 26. Global MuA Recombinase Average Price (US$/Unit) & (2020-2031)
 Figure 27. MuA Recombinase Report Years Considered
 Figure 28. MuA Recombinase Sales Share by Manufacturers in 2024
 Figure 29. Global MuA Recombinase Revenue Share by Manufacturers in 2024
 Figure 30. Global 5 and 10 Largest MuA Recombinase Players: Market Share by Revenue in MuA Recombinase in 2024
 Figure 31. MuA Recombinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 32. Global MuA Recombinase Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 33. North America MuA Recombinase Sales Market Share by Country (2020-2031)
 Figure 34. North America MuA Recombinase Revenue Market Share by Country (2020-2031)
 Figure 35. United States MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Canada MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Europe MuA Recombinase Sales Market Share by Country (2020-2031)
 Figure 38. Europe MuA Recombinase Revenue Market Share by Country (2020-2031)
 Figure 39. Germany MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. France MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. U.K. MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Italy MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Russia MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Asia Pacific MuA Recombinase Sales Market Share by Region (2020-2031)
 Figure 45. Asia Pacific MuA Recombinase Revenue Market Share by Region (2020-2031)
 Figure 46. China MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Japan MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. South Korea MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. India MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Australia MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. China Taiwan MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Southeast Asia MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Latin America MuA Recombinase Sales Market Share by Country (2020-2031)
 Figure 54. Latin America MuA Recombinase Revenue Market Share by Country (2020-2031)
 Figure 55. Mexico MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Brazil MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Argentina MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Colombia MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa MuA Recombinase Sales Market Share by Country (2020-2031)
 Figure 60. Middle East and Africa MuA Recombinase Revenue Market Share by Country (2020-2031)
 Figure 61. Turkey MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 62. Saudi Arabia MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 63. UAE MuA Recombinase Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 64. Global Sales Market Share of MuA Recombinase by Type (2020-2031)
 Figure 65. Global Revenue Market Share of MuA Recombinase by Type (2020-2031)
 Figure 66. Global MuA Recombinase Price (US$/Unit) by Type (2020-2031)
 Figure 67. Global Sales Market Share of MuA Recombinase by Application (2020-2031)
 Figure 68. Global Revenue Market Share of MuA Recombinase by Application (2020-2031)
 Figure 69. Global MuA Recombinase Price (US$/Unit) by Application (2020-2031)
 Figure 70. MuA Recombinase Value Chain
 Figure 71. Channels of Distribution (Direct Vs Distribution)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Human Hyoid Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25O19895
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Genome Reconstruction Tools Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14W20194
Thu Nov 20 00:00:00 UTC 2025

Add to Cart

Global Research Grade Antibodies Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9Y12712
Mon Nov 17 00:00:00 UTC 2025

Add to Cart

Global MuA Recombinase Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36Y19978
Fri Nov 14 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions